Pasadena, CA, United States of America

Osamu Nakanishi

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Schering Aktiengesellschaft, Bayer Schering Pharma Ag, Mitsui Chemicals, Inc.. Active years: 2001-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osamu Nakanishi. Retrieved from https://idiyas.com/inventor/osamu-nakanishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 57.1


Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 133(Granted Patents)


Location History:

  • Chiba, JP (2007)
  • Ashiya, JP (2009)
  • Pasadena, CA (US) (2001 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Osamu Nakanishi: Driving Innovation in Cancer Treatment

Introduction:

Osamu Nakanishi, a brilliant inventor based in Pasadena, CA, is making waves in the field of oncology with his groundbreaking research and patents. With a total of 7 patents to his name, Nakanishi is revolutionizing cancer treatment through his innovative approach to cell differentiation.

Latest Patents:

Nakanishi's most recent patents focus on a cell differentiation inducer, offering a new method for treating a range of malignant tumors, including leukemia, colorectal cancer, ovarian cancer, and more. The compounds he has developed show promise as therapeutic agents for various diseases, with a particular emphasis on their efficacy in combating cancer.

Career Highlights:

Having worked with esteemed companies such as Schering Aktiengesellschaft and Bayer Schering Pharma Ag, Nakanishi brings a wealth of experience to his research endeavors. His contributions to the field have garnered attention for their potential to transform the way we approach cancer therapy.

Collaborations:

Throughout his career, Nakanishi has collaborated with top researchers and colleagues, including Tsuneji Suzuki and Tomoyuki Ando. These partnerships have allowed him to exchange ideas, push boundaries, and further his quest for innovative solutions in the fight against cancer.

Conclusion:

Osamu Nakanishi's dedication to advancing cancer treatment through cell differentiation inducers exemplifies the spirit of innovation in the medical field. His patents stand as a testament to his commitment to improving patient outcomes and driving progress in oncology research. With his continued work, Nakanishi is poised to shape the future of cancer therapy and inspire the next generation of inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…